Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $5362.0.

  • Cumberland Pharmaceuticals' Amortization of Deferred Charges fell 4999.53% to $5362.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25021.0, marking a year-over-year increase of 790.96%. This contributed to the annual value of $28313.0 for FY2024, which is 8239.39% up from last year.
  • Cumberland Pharmaceuticals' Amortization of Deferred Charges amounted to $5362.0 in Q3 2025, which was down 4999.53% from $5361.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Amortization of Deferred Charges' 5-year high stood at $13833.0 during Q1 2021, with a 5-year trough of $110.0 in Q4 2021.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $4296.0 (2023), whereas its average is $5537.4.
  • In the last 5 years, Cumberland Pharmaceuticals' Amortization of Deferred Charges tumbled by 9903.84% in 2021 and then surged by 319909.09% in 2022.
  • Cumberland Pharmaceuticals' Amortization of Deferred Charges (Quarter) stood at $110.0 in 2021, then soared by 3199.09% to $3629.0 in 2022, then rose by 4.99% to $3810.0 in 2023, then soared by 134.54% to $8936.0 in 2024, then tumbled by 40.0% to $5362.0 in 2025.
  • Its Amortization of Deferred Charges was $5362.0 in Q3 2025, compared to $5361.0 in Q2 2025 and $5362.0 in Q1 2025.